Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a simple injection melt away localized fat?

NCT ID NCT07743788

Disease control Sponsor: Antony de Paula Barbosa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 04, 2026 · Last updated Aug 05, 2026 · Updated 1 time

Summary

This study tests whether Mesolipo® injections can safely reduce localized fat. Participants receive the treatment on one side of the body and a comparison injection on the other. Over 90 days, researchers measure fat thickness, side effects, and participant satisfaction to see if the treatment works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mesolipo® (sodium deoxycholate) injections
What this could lead to
If effective, this could offer a non-surgical option for reducing localized fat, potentially improving body contouring outcomes.
What could go wrong
This is a small early-stage trial, so results may not apply broadly. Risks include injection-site reactions and uneven results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

12 people

The number who actually took part.

Started

Jan 2025

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years or older. * Presence of localized adiposity suitable for treatment with the Mesolipo® protocol. * Willingness and ability to provide written informed consent. * Ability to comply with all study procedures and follow-up visits. * Stable body weight for at least 3 months before enrollment. * Agreement to maintain usual diet and physical activity habits throughout the study. Exclusion Criteria: * Pregnancy or breastfeeding. * Known hypersensitivity to sodium deoxycholate or any study product component. * Active infection or inflammatory skin disease at the treatment site. * Previous aesthetic treatment in the target area within the period defined by the protocol. * Severe systemic disease or any condition that, in the investigator's opinion, could interfere with study participation or outcome assessment. * Participation in another clinical trial within the previous 30 days. * Inability or unwillingness to comply with study procedures.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Localized adiposity are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Patient Satisfaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Localized adiposity

Contacts and locations

Locations

  • Instituto Antony Barbosa

    Belo Horizonte, Minas Gerais, 30493-240, Brazil